Literature DB >> 18366150

An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.

Verena Voelter1, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer, Daniel E Speiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18366150      PMCID： PMC2935783     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN： 1424-9634


× No keyword cloud information.
  14 in total

1.  Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

Authors:  Danielle Liénard; Donata Rimoldi; Marie Marchand; Pierre-Yves Dietrich; Nicolas van Baren; Christine Geldhof; Pascal Batard; Philippe Guillaume; Maha Ayyoub; Mikaël J Pittet; Alfred Zippelius; Katharina Fleischhauer; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero; Daniel E Speiser
Journal:  Cancer Immun       Date:  2004-05-19

Review 2.  Shedding light on immunotherapy for cancer.

Authors:  Steven A Rosenberg
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

3.  Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited.

Authors:  Dmitry I Gabrilovich
Journal:  Lancet Oncol       Date:  2007-01       Impact factor: 41.316

4.  A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

Authors:  Daniel E Speiser; Petra Baumgaertner; Catherine Barbey; Verena Rubio-Godoy; Alexandre Moulin; Patricia Corthesy; Estelle Devevre; Pierre-Yves Dietrich; Donata Rimoldi; Danielle Liénard; Jean-Charles Cerottini; Pedro Romero; Nathalie Rufer
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

Authors:  M R Middleton; J J Grob; N Aaronson; G Fierlbeck; W Tilgen; S Seiter; M Gore; S Aamdal; J Cebon; A Coates; B Dreno; M Henz; D Schadendorf; A Kapp; J Weiss; U Fraass; P Statkevich; M Muller; N Thatcher
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

6.  Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Authors:  P B Chapman; L H Einhorn; M L Meyers; S Saxman; A N Destro; K S Panageas; C B Begg; S S Agarwala; L M Schuchter; M S Ernstoff; A N Houghton; J M Kirkwood
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

7.  Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.

Authors:  Gilles Bioley; Camilla Jandus; Sandra Tuyaerts; Donata Rimoldi; William W Kwok; Daniel E Speiser; Jean-Marie Tiercy; Kris Thielemans; Jean-Charles Cerottini; Pedro Romero
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

Authors:  Daniel E Speiser; Danielle Liénard; Nathalie Rufer; Verena Rubio-Godoy; Donata Rimoldi; Ferdy Lejeune; Arthur M Krieg; Jean-Charles Cerottini; Pedro Romero
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

9.  Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.

Authors:  Christopher J Wheeler; Asha Das; Gentao Liu; John S Yu; Keith L Black
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

10.  Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.

Authors:  Maha Ayyoub; Donata Rimoldi; Philippe Guillaume; Pedro Romero; Jean-Charles Cerottini; Danila Valmori; Daniel Speiser
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701
View more
  2 in total

Review 1.  Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.

Authors:  Emanuela M Iancu; Petra Baumgaertner; Sébastien Wieckowski; Daniel E Speiser; Nathalie Rufer
Journal:  J Biomed Biotechnol       Date:  2010-11-14

2.  microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.

Authors:  Nathalie Arts; Stefania Cané; Marc Hennequart; Juliette Lamy; Guido Bommer; Benoît Van den Eynde; Etienne De Plaen
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.